IDEAYA Biosciences Reaches Analyst Target Price
February 22, 2024 at 10:06 AM EST
In recent trading, shares of IDEAYA Biosciences Inc (IDYA) have crossed above the average analyst 12-month target price of $44.10, changing hands for $44.29/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..